Riboxin

200 mg № 10, № 50
Pharmacotherapeutic group
Agents affecting cardio-vascular system
Active ingredient
Riboxin (inosine)
Pharmaceutical form
Film-coated tablets
ATC code
C01EB
RX/OTC
RX
Registration certificate
UA/6774/01/01

General properties

Pharmacotherapeutic group

Cardiac drugs. Inosine.

Therapeutic indications
  • Comprehensive treatment of coronary heart disease (post-myocardial infarction, angina),
  • heart rhythm disorders,
  • cardiac glycosides intoxication drugs,
  • treatment of cardiomyopathies of various origins,
  • myocardiodystrophy (against the background of heavy physical exertion, infectious and endocrine genesis),
  • myocarditis;
  • liver disease (hepatitis, cirrhosis, fatty liver);
  • uroporphyria.
Contraindications

Hypersensitivity to the active substance or to other components of the drug. Gout, hyperuricemia. Restrictions on the reception of Riboxinum is renal failure.

Pharmaceutical characteristics

Main physicochemical properties

Round-shaped tablets, coated, from light yellow to yellow color, the upper and lower surfaces are convex. At the break when viewed under a microscope can see a core surrounded by one continuous layer.

Shelf life
3 years.
Storage

Keep in original package at temperature not exceeding 25 oС.

Keep out of reach of children.

Manufacturer
PJSC "Technolog".
Location
8, Stara Prorizna st., Uman 20300 Cherkasy region, Ukraine.